Sat.Aug 10, 2024

article thumbnail

Opinion: First Opinion readers respond to essays on right to try lies, pharma execs, and more

STAT

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

275
275
article thumbnail

Indian biotech start-ups: Need for pragmatic, pro-active, progressive regulatory milieu

Express Pharma

Indian biotech startup sector – a rapidly growing business segment – has expanded tremendously in the post-COVID era. The biotech startups aim to develop innovative healthcare products, which have huge potential to make substantial contributions to the Indian economy. During the COVID-19 pandemic, a fast regulatory approval process to meet the urgent medical need benefited the bio-entrepreneurs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

EMCrit 381 – Penetrating Neck Trauma – Get Out of the Zones!

EMCrit Project

Penetrating Neck Trauma and how to leave the zone EMCrit Project by Scott Weingart, MD FCCM.

91
article thumbnail

Finerenone Significantly Reduces Cardiovascular Death, Heart Failure in the FINEARTS-HF Trial

Pharmacy Times

Non-steroidal mineralocorticoid receptor antagonist, finerenone, demonstrated improved efficacy compared with existing steroidal treatment for patients.

61
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

52

More Trending

article thumbnail

Andelyn Biosciences and Broad Institute of MIT Enter into License Agreement to include MyoAAV Plasmids in AAV Platform

PharmaTech

With the agreement, Andelyin Biosciences will add MyoAAV plasmids developed by Broad Institute of MIT and Harvard to its AAV Curator Platform.

52
article thumbnail

Leadership and Brutal Honesty

The Honest Apothecary

“Yep, son, we have met the enemy, and he is us.” – Walt Kelly The line above comes from “Pogo”, the humble and contemplative opossum from Walt Kelly’s long-running mid-20th century comic strip. Here, Pogo is expressing his acknowledgement and disappointment that from an environmental perspective, we are actually the enemy.